Anita Milicic

I studied Molecular Biology and Physiology at the University of Belgrade, Serbia, before completing MSc in Genetics and DPhil in Immunology at the University of Oxford.

In 2009 I joined the Jenner Institute in Oxford as the Head of the Adjuvant Facility. I now lead the Vaccine Formulation and Adjuvants Group, developing novel vaccine formulations and delivery modalities. Specifically, our work is focused on the development of new adjuvants with a key emphasis on understanding the adjuvant mechanism of action with the goal of improved vaccine efficacy.

My overall interest is in the processes of immune activation, in particular the interplay between the innate and the adaptive immunity. Vaccine development with the application of vaccine adjuvants provides the ideal base for such studies.